C7H17N2O14P4
Neat
477.11
UNII-VB532S447N; 1632236-60-2; Zoledronic acid tetraphosphonate; 1627731-61-6; VB532S447N; 1H-Imidazolium, 1, 3-bis(2-hydroxy-2, 2-diphosphonoethyl)-; Zoledronic Acid EP Impurity B; 1, 3-Bis(2-hydroxy-2, 2-diphosphonoethyl)-1H-imidazol-3-ium; Zoledronic acid monohydrate impurity B [EP]; hydroxy-[1-hydroxy-2-[3-(2-hydroxy-2, 2-diphosphonoethyl)imidazol-3-ium-1-yl]-1-phosphonoethyl]phosphinate; CQC73161; Zoledronic Acid Impurity 2Zoledronic Acid EP Impurity B; ZOLEDRONIC ACID MONOHYDRATE IMPURITY B [EP IMPURITY]; 1H-Imidazolium, 1, 3-bis(2-hydroxy-2, 2-diphosphonoethyl)-, inner salt; hydrogen (1-hydroxy-2-(1-(2-hydroxy-2, 2-diphosphonoethyl)-1H-imidazol-3-ium-3-yl)-1-phosphonoethyl)phosphonate; Hydrogen (1-hydroxy-2-(3-(2-hydroxy-2 and 2-diphosphonoethyl)-1H-imidazol-3-ium-1-yl)-1-phosphonoethyl)phosphonate
hydroxy-[1-hydroxy-2-[3-(2-hydroxy-2 and 2-diphosphonoethyl)imidazol-3-ium-1-yl]-1-phosphonoethyl]phosphinate
InChI=1S/C7H16N2O14P4/c10-6(24(12,13)14,25(15,16)17)3-8-1-2-9(5-8)4-7(11,26(18,19)20)27(21,22)23/h1-2,5,10-11H,3-4H2,(H7-,12,13,14,15,16,17,18,19,20,21,22,23)